SEI Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.1M Sell
1,021,347
-1,185,973
-54% -$94.9M 0.06% 347
2025
Q4
$210M Sell
2,207,320
-87,080
-4% -$8.54M 0.21% 81
2025
Q3
$224M Sell
2,294,400
-219,064
-9% -$22.7M 0.24% 67
2025
Q2
$270M Sell
2,513,464
-746,140
-23% -$75.5M 0.31% 54
2025
Q1
$329M Sell
3,259,604
-357,675
-10% -$36M 0.42% 34
2024
Q4
$323M Sell
3,617,279
-399,196
-10% -$35.1M 0.41% 36
2024
Q3
$337M Sell
4,016,475
-693,791
-15% -$54.7M 0.44% 37
2024
Q2
$363M Buy
4,710,266
+137,397
+3% +$10.1M 0.51% 30
2024
Q1
$313M Sell
4,572,869
-3,093
-0.1% -$199K 0.46% 39
2023
Q4
$265M Sell
4,575,962
-311,889
-6% -$16.6M 0.42% 43
2023
Q3
$258M Buy
4,887,851
+33,588
+0.7% +$1.76M 0.46% 39
2023
Q2
$263M Buy
4,854,263
+597,940
+14% +$31.2M 0.46% 36
2023
Q1
$213M Buy
4,256,323
+236,280
+6% +$11.1M 0.4% 45
2022
Q4
$186M Sell
4,020,043
-105,752
-3% -$4.58M 0.41% 38
2022
Q3
$160M Buy
4,125,795
+37,175
+0.9% +$1.49M 0.36% 44
2022
Q2
$152M Buy
4,088,620
+502,725
+14% +$20.5M 0.33% 49
2022
Q1
$159M Sell
3,585,895
-595,456
-14% -$25.8M 0.32% 52
2021
Q4
$178M Sell
4,181,351
-18,091
-0.4% -$760K 0.33% 50
2021
Q3
$182M Sell
4,199,442
-501,007
-11% -$22.2M 0.38% 43
2021
Q2
$201M Sell
4,700,449
-181,448
-4% -$7.63M 0.45% 41
2021
Q1
$188M Buy
4,881,897
+430,789
+10% +$16.3M 0.47% 37
2020
Q4
$160M Buy
4,451,108
+39,917
+0.9% +$1.44M 0.41% 43
2020
Q3
$169M Buy
4,411,191
+1,264,742
+40% +$48.7M 0.49% 40
2020
Q2
$110M Buy
3,146,449
+291,403
+10% +$10.5M 0.34% 49
2020
Q1
$93.2M Sell
2,855,046
-881,348
-24% -$34.4M 0.34% 50
2019
Q4
$169M Buy
3,736,394
+180,797
+5% +$7.57M 0.5% 35
2019
Q3
$145M Buy
3,555,597
+24,588
+0.7% +$1.04M 0.37% 51
2019
Q2
$152M Sell
3,531,009
-415,128
-11% -$16M 0.5% 33
2019
Q1
$151M Buy
3,946,137
+121,931
+3% +$4.66M 0.51% 31
2018
Q4
$147M Buy
3,824,206
+27,918
+0.7% +$1.01M 0.52% 29
2018
Q3
$146M Sell
3,796,288
-57,565
-1% -$2.01M 0.53% 30
2018
Q2
$126M Buy
3,853,853
+278,777
+8% +$8.41M 0.43% 37
2018
Q1
$97.7M Sell
3,575,076
-318,944
-8% -$8.67M 0.37% 44
2017
Q4
$96.5M Sell
3,894,020
-1,616,628
-29% -$44.6M 0.34% 51
2017
Q3
$161M Buy
5,510,648
+78,283
+1% +$2.16M 0.57% 22
2017
Q2
$151M Buy
5,432,365
+334,459
+7% +$8.88M 0.6% 16
2017
Q1
$127M Buy
5,097,906
+29,627
+0.6% +$720K 0.56% 17
2016
Q4
$110M Buy
5,068,279
+980,101
+24% +$21.4M 0.53% 21
2016
Q3
$97.3M Buy
4,088,178
+929,435
+29% +$22.2M 0.49% 26
2016
Q2
$73.8M Sell
3,158,743
-242,651
-7% -$5.25M 0.44% 31
2016
Q1
$64M Buy
3,401,394
+555,516
+20% +$9.76M 0.4% 41
2015
Q4
$52.5M Buy
2,845,878
+1,788,637
+169% +$32.1M 0.32% 55
2015
Q3
$17.3M Buy
1,057,241
+91,138
+9% +$1.56M 0.16% 155
2015
Q2
$17.1M Buy
966,103
+700,646
+264% +$12.5M 0.15% 156
2015
Q1
$4.71M Sell
265,457
-68,499
-21% -$1.08M 0.04% 478
2014
Q4
$4.43M Buy
+333,956
New +$4.27M 0.04% 468

Other funds holding BSX

SEI Investments's BSX Position: Q1 2026 in Review

SEI Investments reduced its Boston Scientific (BSX) stake by 54% in Q1 2026, selling an estimated $94.9M and leaving 1,021,347 shares worth $64.1M. The position accounts for 0.06% of the portfolio, ranked #347.

SEI Investments first reported a position in BSX in Q4 2014 and has held it in 46 quarters since. The position peaked at $363M in Q2 2024. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • SEI Investments held 1,021,347 shares of Boston Scientific worth $64.1M as of Q1 2026.
  • SEI Investments sold 1,185,973 Boston Scientific shares in Q1 2026, an estimated $94.9M.
  • Boston Scientific made up 0.06% of SEI Investments's portfolio in Q1 2026, its #347 holding.
  • SEI Investments first reported a position in Boston Scientific in Q4 2014 and has held it in 46 quarters since.
  • SEI Investments's Boston Scientific position peaked at $363M in Q2 2024.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.